Clinical CareOhio Health System Launches Aging Institute
ProMedica's initiative is designed to help the country rise to the challenge of the exploding senior population.
Clinical CarePowerful Antibiotics Frequently Prescribed for Discharged Patients
Even as hospitals try to cut back on prescribing powerful antibiotics for their patients, many of those patients still head...
InnovationWhen Parkinson's Meets AI: Models for Disease Progression Expected
The Michael J. Fox Foundation partners with IBM to analyze "treasure trove" of data.
Clinical CareTop Cancer Doctor, Forced Out Over Ties to Drug Makers, Joins Their Ranks
AstraZeneca has hired Dr. José Baselga, the former chief medical officer at Memorial Sloan Kettering, to lead its cancer research...
Clinical CareHospital Readmissions Reduction Program's Impact Downgraded
The reduction in readmission rates is about half as large as previously reported, researchers say.
FinanceWhy The U.S. Remains The World's Most Expensive Market For 'Biologic' Drugs
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from 'biosimilars.' It's a very...
Clinical CareU.S. News' Top-Ranked Cardio Hospitals Really Do Provide Higher Quality Care
The magazine's renowned list of 50 top-ranked hospitals for cardiovascular care outperformed 3,500 non-ranked hospitals on key metrics, but saw...
Clinical CareHepatitis C Treatment Times Cut in Half, Still Effective
Models show that personalized patient drug regimens can reduce treatment times and save money without jeopardizing efficacy.
Clinical CareYou're Probably Wasting Money on Cardiac Telemetry Overuse
Inappropriate utilization of cardiac telemetry is wasteful spending with no significant clinical benefit.
InnovationCould Nanotechnology Innovation Reduce Blood Clotting and Infections From Implants?
McMaster researchers develop surface coating that repels bacteria, viruses, and living cells.
Sloan Kettering Cancer Researchers Correct the Record by Revealing Company Ties
The hospital's chief medical officer resigned last month after failing to disclose company ties in medical journals. Now researchers, including...
StrategyFacing Crisis, Sloan Kettering Tells Exec to Hand Over Profits From Biotech
A vice president at Memorial Sloan Kettering received a stake of nearly $1.4 million in a biotech company for representing...